Related Experiment Videos

Evaluation of the current prognostic role of cardiogenic syncope

Filippo Numeroso1, Gianluigi Mossini, Giuseppe Lippi

  • 1Emergency Department, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy. fnumeroso@ao.pr.it

Internal and Emergency Medicine
|December 19, 2012
PubMed

Insights

Cardiogenic syncope, originating from heart conditions, leads to worse outcomes and higher mortality compared to non-cardiogenic syncope. This study confirms cardiogenic syncope indicates a poorer prognosis.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Previous studies suggest higher mortality in cardiogenic syncope.
  • Concerns exist that underlying heart disease, not syncope itself, predicts mortality risk.
  • The prognostic value of syncope type requires further investigation.

Purpose of the Study:

  • To prospectively compare the prognosis of cardiogenic versus non-cardiogenic syncope.
  • To evaluate short-term and long-term adverse events in syncopal patients.
  • To determine if syncope type influences patient outcomes.

Main Methods:

  • Prospective cohort study of 200 syncopal patients.
  • Patients admitted to the Emergency Department Observation Unit.
  • Comparison of outcomes at 1 month and 1 year post-discharge.

Main Results:

  • Cardiogenic syncope was linked to adverse events at both short and long term.
  • Patients with cardiogenic syncope experienced higher rates of recurrence, procedures, cardiovascular events, and death.
  • Despite advances in cardiovascular disease treatment, cardiogenic syncope prognosis remains poor.

Conclusions:

  • Cardiogenic syncope is associated with a significantly worse prognosis compared to non-cardiogenic syncope.
  • The findings underscore the importance of identifying the cause of syncope for risk stratification.
  • Early identification and management of cardiogenic syncope are crucial for improving patient outcomes.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...